| Dr Cameron Richard Harrison, MD | |
|
280 Exempla Cir, Lafayette, CO 80026-3370 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Cameron Richard Harrison |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 280 Exempla Cir, Lafayette, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891905980 | NPI | - | NPPES |
| 88400085 | Medicaid | CO | |
| 024041 | Other | CO | KAISER COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | A 112829 (California) | Secondary |
| 207N00000X | Dermatology | 053327 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Permanente Medical Group Pc | 1254238454 | 1113 |
News Archive
An analysis of 20 years of data on the health of over 900 adults has found that long-term use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, cuts the risk for oral cancer in smokers by half.
Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer.
"Sustainable development cannot be realized unless hunger and malnutrition are eradicated, the [Food and Agriculture Organization (FAO)] said in a policy document prepared for the Rio+20 Summit to be held in June in Rio de Janeiro," an FAO press release reports.
Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug.
Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.
› Verified 7 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
An analysis of 20 years of data on the health of over 900 adults has found that long-term use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, cuts the risk for oral cancer in smokers by half.
Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer.
"Sustainable development cannot be realized unless hunger and malnutrition are eradicated, the [Food and Agriculture Organization (FAO)] said in a policy document prepared for the Rio+20 Summit to be held in June in Rio de Janeiro," an FAO press release reports.
Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug.
Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cameron Richard Harrison, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Dr Cameron Richard Harrison, MD 280 Exempla Cir, Lafayette, CO 80026-3370 Ph: (303) 338-4545 |
News Archive
An analysis of 20 years of data on the health of over 900 adults has found that long-term use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, cuts the risk for oral cancer in smokers by half.
Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer.
"Sustainable development cannot be realized unless hunger and malnutrition are eradicated, the [Food and Agriculture Organization (FAO)] said in a policy document prepared for the Rio+20 Summit to be held in June in Rio de Janeiro," an FAO press release reports.
Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug.
Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.
› Verified 7 days ago
Dr. Michael Keith Lichtman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Megan E Weber, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Timothy E Grayson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Nicole M. Annest, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Denise A Kolbet, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-3800 | |
Dr. Tracy A. Haines, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Diana L Hartsoch, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 720-536-7768 |